According to IMARC Group’s latest report, titled “Immunohematology Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The global immunohematology market size reached US$ 1.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.4 Billion by 2027, exhibiting a growth rate (CAGR) of 4.97% during 2022-2027.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Immunohematology refers to a branch of medical sciences that studies the reactions between blood antigens, antibodies and blood proteins in relation to immune response. It is essential in blood banking, wherein it is used to prepare blood components for transfusion and reducing transfusion-related fatalities, like HIV and thalassemia. Immunohematology also forms a critical element of the development of transfusion medicine.
Request Free Sample Report: https://www.imarcgroup.com/immunohematology-market/requestsample
Market Trends:
The global immunohematology market is primarily driven by the growing instances of hematological disorders around the globe. The market growth is further supported by public and private investments to increase the number of blood banks and awareness programs regarding blood donation and screening. Furthermore, improvements in healthcare infrastructure and the development of next-generation immunohematology devices have enhanced the efficacy of the diagnosis and minimized analysis time and the risk of human errors. Moreover, the development of innovative transfusion systems and fully automated instruments are expected to create a positive outlook for the market.
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/immunohematology-market
List of Key Companies Covered in this Market Report:
Abbott
Antisel
BD (Becton Dickinson and Company)
Beckman Coulter Inc. (Danaher Corporation)
Bio-Rad Laboratories Inc.
Hoffmann-La Roche Ltd.,
Grifols S.A.
Merck KGaA
MTC Invitro Diagnostics AG
Ortho-Clinical Diagnostics Inc (The Carlyle Group)
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc.
The report has segmented the market on the basis of product, technology, application, end -user and geography
Breakup by Product:
Analyzing Systems
Reagents and Consumables
Breakup by Technology:
Biochips
Gel Cards
Microplates
Polymerase Chain Reaction
Erythrocyte-Magnetized Technology (EMT)
Others
Breakup by Application:
Blood-Related Disorders
HIV
Hepatitis
Blood Transfusion
Others
Breakup by End-User:
Hospitals
Blood Banks
Diagnostic Laboratories
Others
Breakup by Geography:
North America (U.S. & Canada)
Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
Latin America (Brazil, Mexico)
Middle East & Africa
Key highlights of the report:
Market Performance (2016-2021)
Market Outlook (2022- 2027)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Twitter: https://twitter.com/ImarcServices
